BG Medicine, Inc. - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - November 13, 2012

Attached files
FileFilename
EX-31.1 - EX-31.1 - BG Medicine, Inc.d398643dex311.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R3.htm
10-Q - FORM 10-Q - BG Medicine, Inc.d398643d10q.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R8.htm
EXCEL - IDEA: XBRL DOCUMENT - BG Medicine, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R9.htm
EX-32 - EX-32 - BG Medicine, Inc.d398643dex32.htm
EX-31.2 - EX-31.2 - BG Medicine, Inc.d398643dex312.htm
EX-10.2 - EX-10.2 - BG Medicine, Inc.d398643dex102.htm
EX-10.1 - EX-10.1 - BG Medicine, Inc.d398643dex101.htm
v2.4.0.6
Fair Value of Financial Instruments (Details 1) (USD $)
 9 Months Ended 12 Months Ended
Sep. 30, 2012
Dec. 31, 2011
Fair value of the common stock warrants determined under Black-Scholes option pricing method    
Weighted-average risk-free interest rate 1.96%  
Weighted-average remaining contractual term 10 years  
Expected volatility 70.00%  
Fair value of underlying shares of stock $ 8.51  
Common Stock Warrant Liability [Member]
    
Fair value of the common stock warrants determined under Black-Scholes option pricing method    
Weighted-average risk-free interest rate 0.55% 0.90%
Expected dividend yield 0.00% 0.00%
Weighted-average remaining contractual term 4 years 6 months 5 years 3 months 18 days
Expected volatility   70.00%
Fair value of underlying shares of stock $ 3.68 $ 4.72
Common Stock Warrant Liability [Member] | Maximum [Member]
    
Fair value of the common stock warrants determined under Black-Scholes option pricing method    
Expected volatility 75.00%  
Common Stock Warrant Liability [Member] | Minimum [Member]
    
Fair value of the common stock warrants determined under Black-Scholes option pricing method    
Expected volatility 74.00%  

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by BG Medicine, Inc. and has no official or unofficial affiliation with BG Medicine, Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.